drugset / Trial / NCT02287623

Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study

NCT02287623 ↗

Phase 4 Completed 60 enrolled University of Minnesota
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary objective of this study is whether one local anesthetic, liposomal bupivacaine, provides improved pain control and decreased opioid use compared to bupivacaine when injected during a transversus abdominis plane block for donor nephrectomy patients.

Timeline

Start
2013-05
Primary completion
2014-07
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified — —

Indications

No indication recorded.